Untreated obstructive sleep apnea may be costing the UK and US economies billions of pounds/dollars in lost productivity ...
Untreated sleep apnea in workplace causes massive productivity losses in the US and UK, urging immediate workplace screening to improve safety and economic output.
News-Medical.Net on MSN
Untreated sleep apnea may cost the UK and US billions annually
Untreated obstructive sleep apnea may be costing the UK and US economies billions of pounds/dollars in lost productivity every year, with a considerable proportion of working age adults experiencing ...
Women over 50 with sleep apnea rarely look like the textbook patient — they don't snore loudly, they don't fit the screening ...
Can SleepZee help with sleep apnea? The thesleepzee.com website states the product can "alleviate obstructive sleep apnea symptoms." Sleep apnea is a medical condition that requires professional ...
Everyday Health on MSN
CPAP vs. medication: Which obstructive sleep apnea (OSA) treatment is more effective?
Compare the efficacy, benefits, and drawbacks of CPAP therapy and tirzepatide (Zepbound), two of the best treatments for sleep apnea.
ProSomnus Sleep Technologies ("the Company"), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy® and pioneer in Smart Sleep Medicine™, today announced a strategic investment from Catalio ...
ProSomnus Sleep Technologies ("the Company"), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy (R) and pioneer in Smart Sleep Medicine (TM), today announced a strategic investment from ...
Q2 2026 Earnings Call February 26, 2026 6:00 PM ESTCompany ParticipantsKaren Borg - Co-CEO & Executive DirectorYe-Fei Guo ...
(Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results for the fourth quarter and the full year ended ...
Q4 2025 Earnings Call February 24, 2026 5:00 PM ESTCompany ParticipantsLorna Williams - Senior Vice President of Investor ...
StockStory.org on MSN
A look back at medical devices & supplies - specialty stocks’ Q4 earnings: Haemonetics (NYSE:HAE) vs the rest of the pack
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results